Vanessa F Schmidt, Özlem Cangir, Lutz Meyer, Constantin Goldann, Susanne Hengst, Richard Brill, Susanne von der Heydt, Milton Waner, Daniel Puhr-Westerheide, Osman Öcal, Muzaffer Reha Ümütlü, Nabeel Mansour, Jan Rudolph, Alena Sint, Florian Obereisenbuchner, Beate Häberle, Jens Ricke, Max Seidensticker, Walter A Wohlgemuth, Moritz Wildgruber
OBJECTIVES: To evaluate the safety and clinical outcome of bleomycin electrosclerotherapy (BEST) for treating extracranial slow-flow malformations. METHODS: In this retrospective investigation of a multicenter cohort presenting symptomatic slow-flow malformations, patient records were analyzed with respect to procedural details and complications. A treatment-specific, patient-reported questionnaire was additionally evaluated, obtained 3-12 months after the last treatment, to assess the subjective outcomes, including mobility, aesthetic aspects, and pain, as well as the occurrence of postprocedural skin hyperpigmentation...
April 16, 2024: European Radiology